Name Speakers
12:00 PM - 12:30 PM (CEST)
Understanding Myc-associated Proteins to Explore Strategies to Inhibit Their FunctionMartin Eilers - University of Würzburg
12:30 PM - 1:00 PM (CEST)
Structure, Function, and Dynamics of the Dimerisation and DNA-Binding Domain of the Oncogenic Transcription Factor MycRobert Konrat - University of Vienna
1:30 PM - 2:00 PM (CEST)
Roundtable Discussion:Exploring the Unknown Effects of Drugging Transcription FactorsCharles Lin - Kronos Bio
2:10 PM - 2:40 PM (CEST)
OBF1/OCT Factors as Novel Targets in Germinal Center-Derived LymphomasPatrick Matthias - Friedrich Miescher Institute for Biomedical Research
2:40 PM - 3:10 PM (CEST)
New Routes towards Small Molecule Mediated Degradation of Transcription FactorsEric Fischer - Dana-Farber Cancer Institute
Name Speakers
12:00 PM - 12:30 PM (CEST)
Direct inhibition of MYC with Stabilised Antisense OligonucleotidesChristopher Ott - Harvard Medical School
12:30 PM - 1:00 PM (CEST)
Attacking Myc with Cell-Penetrating Mini-ProteinsLaura Soucek - Peptomyc; VHIO
1:30 PM - 2:00 PM (CEST)
Roundtable Discussion:Additional Strategies to Target Transcription FactorsGiorgio Galli - NIBR | Novartis
2:10 PM - 2:40 PM (CEST)
Drugging Oncogenic Transcription Factors with Enhancer Activity ScreenJoey Azofeifa - Arpeggio Bio
Name Speakers
12:00 PM - 12:30 PM (CEST)
Identifying Inhibitors of Oncogenic Transcription Programs Through a Small Molecule Microarray Discovery PlatformCharles Lin - Kronos Bio
12:30 PM - 1:00 PM (CEST)
Identifying and Characterising TF Networks Dependencies in Urogenital CancersGiorgio Galli - NIBR | Novartis
1:00 PM - 1:30 PM (CEST)
Platforms for the Generation and High-Throughput Screening of Microcycle libraries for inhibitors for protein-protein and protein-DNA interactionsAli Tavassoli - University of Southampton
2:00 PM - 2:30 PM (CEST)
Roundtable Discussion:Tackling the Protein-DNA and Protein-Protein binding problemAllan Jordan - Sygnature Discovery
2:40 PM - 3:10 PM (CEST)
Reimagining Druggability using Chemoproteomic PlatformsDaniel Nomura - University of California, Berkeley
Name Speakers
12:00 PM - 12:30 PM (CEST)
Clinical Development of CCS1477: A First-Class Small Molecule Inhibitor to Drug TranscriptionWill West - CellCentric
12:30 PM - 1:00 PM (CEST)
GT19077, a c-Myc/Max PPI Small molecule Inhibitor to Selectively Target c-Myc-Additive B-cell and Myeloid MalignanciesLiandong Ma - Kintor Pharmaceuticals
1:30 PM - 2:00 PM (CEST)
Roundtable Discussion:New Directions in Targeting Transcription Factors: Oncology and BeyondGiorgio Galli - NIBR | Novartis
2:10 PM - 2:40 PM (CEST)
Mapping RNA Target Via Small Molecule Microarray ToolsJohn Schneekloth - National Cancer Institute-Frederick